FIELD: chemistry, pharmacology.
SUBSTANCE: claimed invention relates to agonist of receptor of glucagone-like peptide-1, which can be applied for treatment of diseases, caused by disturbance of glycometabolism, such as type II diabetes, insensibility to insulin or obesity. In structural formula each of Ar1 and Ar2 independently represents substituted phenyl, and group-substituents represent one, two or three groups selected from C1-C6alkoxyl, C1-C6-alkanoylamino, which is substituted with hydroxyl (which contains groups-substituents, including hydroxyl); C3-C6-cyclolkanoylamino, C2-C6-lkenoylamino; banzoylamino, banzyloxy C1-C6-alkanoylamino, thenoyloxy, tret-butoxyformamido, adamantanformamido; and mandeloylamino; X represents O; Y represents O. Invention also relates to method of obtaining agonist, and to its application for obtaining medication for treatment of diseases caused by disturbance of glycometabolism.
EFFECT: obtaining medication for treatment of diseases caused by disturbance of glycometabolism.
8 cl, 4 ex, 2 tbl, 2 dwg
Title | Year | Author | Number |
---|---|---|---|
SUBSTITUTED 2H-PYRAZOLE DERIVATIVE | 2016 |
|
RU2722363C2 |
COMPOUND AS CYCLIN-DEPENDENT KINASE 9 INHIBITOR AND USE THEREOF | 2020 |
|
RU2819762C1 |
CELL NECROSIS INHIBITOR, METHOD FOR ITS PRODUCTION AND APPLICATION | 2019 |
|
RU2793918C2 |
NOVEL DIPEPTIDYL PEPTIDASE IV INHIBITORS, SYNTHESIS METHODS THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID INHIBITORS | 2007 |
|
RU2443687C2 |
PYRIMIDINE COMPOUND WITH CONDENSED RINGS, ITS INTERMEDIATE COMPOUND, METHOD OF PRODUCING, COMPOSITION AND USE | 2016 |
|
RU2732576C2 |
DERIVATIVES OF GALANTHAMINE, METHOD FOR THEIR PREPARING, MEDICINAL AGENT BASED ON THEREOF AND METHOD FOR ITS PREPARING | 2001 |
|
RU2241001C2 |
COMPOUND RELATED TO VITAMIN A AND METHODS OF ITS SYNTHESIS | 1998 |
|
RU2188193C2 |
PYRIDINE DERIVATIVES USED AS QUICKLY DISSOCIABLE DOPAMINE RECEPTOR 2 ANTAGONISTS | 2008 |
|
RU2480462C2 |
INDOLES USEFUL IN TREATMENT ANDROGEN RECEPTORS BOUND DESEASES | 2003 |
|
RU2328484C2 |
TRPVI AGONISTS, PREPARATIONS CONTAINING SAID AGONISTS AND USE THEREOF | 2005 |
|
RU2379282C2 |
Authors
Dates
2008-12-27—Published
2003-12-25—Filed